menu
    • menu

    Company profile for SpringWorks Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that identifies and advances promising science and pioneers efficient pathways for drug development for patients with severe rare diseases and cancer. We are a “start-up with a head start,” having launched in 2017 with a portfolio of promising clinical-stage therapies and with strong financial backing from a group of leading life science investors and p...
    SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that identifies and advances promising science and pioneers efficient pathways for drug development for patients with severe rare diseases and cancer. We are a “start-up with a head start,” having launched in 2017 with a portfolio of promising clinical-stage therapies and with strong financial backing from a group of leading life science investors and pharmaceutical industry partners. Our lead pipeline programs are for rare oncology indications: a gamma secretase inhibitor is in a Phase 3 clinical trial for the treatment of desmoid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SpringWorks TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Washington Blvd, Stamford, CT 06902,
    Telephone
    Telephone
    +1-203-883-9490
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://springworkstx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/springworks-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/springworkstx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Springworks Therapeutics Publishes Long-Term Data on Ogsiveo
    Springworks Therapeutics Publishes Long-Term Data on Ogsiveo

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3169927/0/en/SpringWorks-Therapeutics-Announces-Publication-of-Long-Term-Efficacy-and-Safety-Data-from-the-Phase-3-DeFi-Trial-of-OGSIVEO-nirogacestat-in-Adults-with-Desmoid-Tumors-in-the-Journa.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    European Commission grants approval of Ogsiveo
    European Commission grants approval of Ogsiveo

    18 Aug 2025

    // PRESS RELEASE

    https://ir.springworkstx.com/news-releases/news-release-details/european-commission-grants-approval-ogsiveor-nirogacestat

    PRESS RELEASE
    18 Aug 2025
    Share Share
    EU Grants Conditional Approval of Ezmekly for Patient with NF1-PN
    EU Grants Conditional Approval of Ezmekly for Patient with NF1-PN

    18 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/18/3118038/0/en/European-Commission-Grants-Conditional-Approval-of-EZMEKLY-mirdametinib-for-the-Treatment-of-Adult-and-Pediatric-Patients-with-NF1-PN.html

    GLOBENEWSWIRE
    18 Jul 2025
    Share Share
    Merck KGaA Finalizes SpringWorks Deal to Grow Healthcare
    Merck KGaA Finalizes SpringWorks Deal to Grow Healthcare

    01 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250630369209/en/Merck-KGaA-Darmstadt-Germany-Completes-Acquisition-of-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-its-Healthcare-Business

    BUSINESSWIRE
    01 Jul 2025
    Share Share
    SpringWorks Therapeutics gets CHMP nod for Nirogacestat
    SpringWorks Therapeutics gets CHMP nod for Nirogacestat

    20 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/20/3102677/0/en/SpringWorks-Therapeutics-Receives-Positive-CHMP-Opinion-for-Nirogacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors.html

    GLOBENEWSWIRE
    20 Jun 2025
    Share Share
    SpringWorks Therapeutics gets CHMP approval for Mirdametinib
    SpringWorks Therapeutics gets CHMP approval for Mirdametinib

    23 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/23/3087438/0/en/SpringWorks-Therapeutics-Receives-Positive-CHMP-Opinion-for-Mirdametinib-for-the-Treatment-of-Adult-and-Pediatric-Patients-with-NF1-PN.html

    GLOBENEWSWIRE
    23 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search